Immunic, Inc. (IMUX) Dividend History

Immunic, Inc. (IMUX) is a clinical-stage biopharmaceutical company focused on developing oral therapies for autoimmune and inflammatory diseases. The company's pipeline includes immune-modulating treatments aimed at conditions such as multiple sclerosis, ulcerative colitis, and psoriasis. Immunic's approach leverages innovative small molecule compounds designed to target specific pathways involved in immune system regulation.

1200 Avenue Of The Americas, New York, X1, 10036
Phone: (332) 255-9818
Website:

Dividend History

Immunic, Inc. currently does not pay dividends

Company News

  • The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. OPKO Health The Trade: OPKO Health, Inc. (NASDAQ: OPK) 10% owner Frost Gamma Investments Trust acquired a total of 500,000 shares an average price of ...

    Benzinga
    Featured Companies: OPK
  • Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares climbed 87.1% to $3.18 after the company announced it secured a majority stake in True Gold Consortium. PowerFleet, Inc. (NASDAQ: PWFL) gained 42% to $2.80. Powerfleet and MiX Telematics entered into a definitive agreement to form one of the largest mobile asset Internet of Things Software-as-a-Service providers in the world. SaverOne 2014 Ltd (NASDAQ: SVRE) rose 31.1% to $0.7010. Intrusion Inc. (NASDAQ: INTZ) gained 30.4% to $0.4565. Intrusion has been awarded a $5 million agreement with a large telecommunications provider to provide Intrusion Shield support for its data centers. Startek, Inc. (NYSE: SRT) gained 29.1% to $4.21 as the company agreed to be acquired by funds managed by CSP Management Limited for $4.30 per share in cash. CISO Global Inc. (NASDAQ: CISO) shares climbed 29.1% to $0.18. CISO Global said its Argo Edge Cloud Security Platform has been independently valued at $49 million. Mobilicom Limited (NASDAQ: MOB) climbed 27.1% to $1.8050, after gaining more than 11% on Monday. PGT Innovations, Inc. (NYSE: PGTI) surged 21.8% to $31.92. NanoString Technologies, Inc. (NASDAQ: NSTG) gained 20.7% to $1.4506 after the company disclosed third-quarter preliminary results and a reorganization designed to accelerate its path to profitability. Erasca, Inc. (NASDAQ: ERAS) rose 20.6% to $2.6550. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) climbed 19% to $0.2209. MDxHealth SA (NASDAQ: MDXH) gained 18.5% to $2.82. MDxHealth reported preliminary revenues of $19.3 million for the third quarter, representing an increase of 73% year over year. Lexicon Pharmaceuticals, Inc. (NASDAQ:

    Benzinga
  • Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. Immunic, Inc. (NASDAQ: IMUX) shares gained 13.2% to $1.80 in pre-market trading after the company disclosed positive interim data from Phase 2 CALLIPER trial of vidofludimus calcium in progressive multiple sclerosis. Tempest Therapeutics, Inc. (NASDAQ: TPST) shares rose 21.1% to $0.2785 in pre-market trading, after falling 8% on Monday. Mobilicom Limited (NASDAQ: MOB) rose 41.1% to $2.05 in pre-market trading, after gaining more than 11% on Monday. SMX (Security Matters) Public Limited Company (NASDAQ: SMX) shares climbed 18.2% to $2.01 in pre-market trading, after jumping 18% on Monday. Domaine Des Massifs and SMX recently formed a strategic collaboration to revolutionize traceability. ContraFect Corporation (NASDAQ: CFRX) rose 16.8% to $0.5277 in pre-market trading, after surging more than 12% on Monday. ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 13.8% to $3.07 in pre-market trading. ParaZero Technologies shares jumped 133% on Monday ...

    Benzinga
    Featured Companies: FTFT LXRX MSS PRZO RETO SMX SPCB TPST WINT
  • Immunic (IMUX) reports positive results from the maintenance phase of the phase II study evaluating its lead candidate, vidofludimus calcium, to treat patients with ulcerative colitis.

    Zacks Investment Research
    Featured Companies: CRSP KALA KOD
  • Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite Delivery/Indefinite Quantity contract for high energy laser beams. Liminal BioSciences Inc. (NASDAQ: LMNL) gained 73.3% to $6.55 after Thomvest submitted an unsolicited non-binding transaction proposal to acquire Liminal on an all cash basis. InflaRx N.V. (NASDAQ: IFRX) shares climbed 49.8% to $5.65 on continued upward momentum after the company yesterday announced it received FDA EUA for Gohibic for the treatment of critically ill COVID-19 patients. Today, LifeSci Capital upgraded the stock from Market Perform to Outperform. Freight Technologies, Inc. (NASDAQ: FRGT) gained 35% to $2.31 after the company reported the highest monthly increase in new clients since Fr8App's platform inception. Also, the company expects 2023 revenue guidance of $36 million, representing a nearly 40% growth from Fr8App's 2022 full-year revenue. YS Biopharma Co., Ltd. (NASDAQ: YS) jumped 23.3% to $1.90. YS Biopharma recently announced interim Phase 2 safety and immunogenicity data for its PIKA recombinant Covid-19 vaccine. 180 Life Sciences Corp. (NASDAQ: ATNF) gained 23% to $2.19. SenesTech, Inc. (NASDAQ: SNES) gained 22% to $1.88 after the company announced it signed a distribution agreement with Target Specialty Products for ContraPest. Immunic, Inc. (NASDAQ: IMUX) jumped 20.8% to $1.7650 after the company reported data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset, vidofludimus calcium (IMU-838), in patients with moderate-to-severe ulcerative colitis. Bit Origin Ltd (NASDAQ: BTOG) surged 20.8% to $0.29. TransCode Therapeutics, Inc. (NASDAQ: RNAZ) surged 19.1% to $0.3931 after the company announced that it has been awarded the third year of a Fast-Track Small Business Innovation Research grant from the NIH to support the clinical evaluation of TTX-MC138. a.k.a. Brands Holding Corp. (NYSE:

    Benzinga
Dividend data last updated 06/07/2025 23:48:04 UTC